Benzinga | Oct 8, 2021 08:00AM EDT

Morgan Stanley Maintains Equal-Weight on Jazz Pharmaceuticals, Lowers Price Target to $174

Morgan Stanley analyst Jeffrey Hung maintains Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Equal-Weight and lowers the price target from $176 to $174.